Tu1754 – Safety and Tolerability of Bt-11, a Gut-Restricted Lancl2 Agonist, in a Randomized, Double-Blind, Placebo-Controlled Phase I Study in Normal Healthy Volunteers
Leber, Andrew, Hontecillas, Raquel, Zoccoli-Rodriguez, Victoria, Colombel, Jean Frederic, Chauhan, Jyoti, Bassaganya-Riera, JosepVolume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(19)39740-9
Date:
May, 2019
File:
PDF, 132 KB
english, 2019